Pharmacotherapy for obesity: a quantitative analysis of four decades of published randomized clinical trials
The DOI matches its Crossref record; 22 of the 23 references it cites were found in a registry or an index.
Abstract
Aim This article provides the first comprehensive meta-analysis of randomized clinical trials of medications for obesity.Method Based on stringent inclusionary criteria, a total of 108 studies were included in the final database. Outcomes are presented for comparisons of single and combination drugs to placebo and for comparisons of medications to one another.Result Overall, the medications studied produced medium effect sizes. Four drugs produced large effect sizes (ie d>0.80; amphetamine, benzphetamine, fenfluramine and sibutramine). The placebo-subtracted weight losses for single drugs vs placebo included in the meta-analysis never exceeded 4.0 kg. No drug, or class of drugs, demonstrated clear superiority as an obesity medication. Effects of methodological factors are also presented along with suggestions for future research.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In a meta-analysis of phentermine monotherapy clinical trials, the placebo-corrected reduction in body weight with phentermine was less than 4 kg”
From Anti-Obesity Medications and Investigational Agents: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022 (2022) · cites this paper as [49]
In the citing paper
“The pooled analysis showed that those treated with phentermine along with diet and lifestyle lost 3.6 kg more than patients treated with diet and lifestyle alone.”
From Obesity‐Related Hypertension: Pathogenesis, Cardiovascular Risk, and Treatment: A Position Paper of The Obesity Society and the American Society of Hypertension (2013) · cites this paper as [196]
Citations
Cites
Statistical Methods for Meta-Analysis
Wasserman, S., Hedges, L. V., & Olkin, I. (1988) · Journal of Educational Statistics · doi:10.2307/1164953 · Cited by 10,326
Cohen, J. (1992) · Psychological Bulletin · doi:10.1037//0033-2909.112.1.155 · Cited by 8,771
Kopelman, P. G. (2000) · Nature · doi:10.1038/35007508 · Cited by 4,795
Statistical Methods for Meta-Analysis.
Freeman, P. R., Hedges, L. V., & Olkin, I. (1986) · Biometrics · doi:10.2307/2531069 · Cited by 4,784
Lipsey, M. W., & Wilson, D. B. (1993) · American Psychologist · doi:10.1037/0003-066x.48.12.1181 · Cited by 2,033
Estimation of effect size from a series of independent experiments.
Hedges, L. V. (1982) · Psychological Bulletin · doi:10.1037//0033-2909.92.2.490 · Cited by 1,062
The Handbook of Research Synthesis
Hanka, R. (1994) · BMJ · doi:10.1136/bmj.309.6952.488a · Cited by 1,052
Haller, C. A., & Benowitz, N. L. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012213432502 · Cited by 956
Effect of sibutramine on weight maintenance after weight loss: a randomised trial
James, W. P. T., Astrup, A., Finer, N., Hilsted, J., Kopelman, P., Rössner, S., Saris, W. H. M., & Gaal, L. F. V. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03491-7 · Cited by 817
Phenylpropanolamine and the Risk of Hemorrhagic Stroke
Kernan, W. N., Viscoli, C. M., Brass, L. M., Broderick, J. P., Brott, T., Feldmann, E., Morgenstern, L. B., Wilterdink, J. L., & Horwitz, R. I. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012213432501 · Cited by 611
Research works printed but not linked: 3
- Scoville BA . Review of amphetamine like drugs by the Federal Drug Administration: clinical data and value judgments. In: G Bray (ed). Obesity in perspective, DHEW publication no. (NIH) 75–708. US Government Printing Office: Washington, DC 1973.
- Shadish, WR, Haddock, CK . Combining estimates of effect size. In: H Cooper, LV Hedges (eds). The handbook of research synthesis Russell Sage: New York 1994 261–281.
- National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) . Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity: the evidence report US Government Press: Washington DC 1998.
Cited by
Items 101–200 of 303
Boh, B., Lemmens, L. H. J. M., Jansen, A. T. M., Nederkoorn, C., Kerkhofs, V., Spanakis, G., Weiß, G., & Roefs, A. (2016) · Trials · doi:10.1186/s13063-016-1280-x · Cited by 47
Why do we need drugs to treat the patient with obesity?
Bray, G. A. (2013) · Obesity · doi:10.1002/oby.20394 · Cited by 38
Combination Drugs for Treating Obesity
Greenway, F. L., & Bray, G. A. (2010) · Current Diabetes Reports · doi:10.1007/s11892-010-0096-4 · Cited by 41
Grabarczyk, T. R. (2018) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2048 · Cited by 37
Proietto, J., & Baur, L. A. (2004) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2004.tb06031.x · Cited by 48
CNS-targeting pharmacological interventions for the metabolic syndrome
Stemmer, K., Müller, T. D., DiMarchi, R. D., Pfluger, P. T., & Tschöp, M. H. (2019) · Journal of Clinical Investigation · doi:10.1172/jci129195 · Cited by 36
Drug Insight: appetite suppressants
Bray, G. A. (2005) · Nature Clinical Practice Gastroenterology & Hepatology · doi:10.1038/ncpgasthep0092 · Cited by 35
The 5-HT6 Receptor as a Target for Developing Novel Antiobesity Drugs
Heal, D. J., Gosden, J., & Smith, S. L. (2011) · International review of neurobiology · doi:10.1016/b978-0-12-385902-0.00004-8 · Cited by 33
DeLaet, D. E., DeLaet, D., & Schauer, D. P. (2008) · Europe PMC (PubMed Central) · Cited by 30
The unrelenting fall of the pharmacological treatment of obesity
Dalmazi, G. D., Vicennati, V., Pasquali, R., & Pagotto, U. (2013) · Endocrine · doi:10.1007/s12020-013-9983-1 · Cited by 36
Blanck, H. M., Khan, L. K., & Serdula, M. K. (2004) · Preventive Medicine · doi:10.1016/j.ypmed.2004.04.040 · Cited by 30
Milbank, E., Martínez, M. C., & Andriantsitohaina, R. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.11.002 · Cited by 33
Espeland, M. A., Dotson, K., Jaramillo, S. A., Kahn, S. E., Harrison, B. W., Montez, M. G., Foreyt, J. P., Montgomery, B., & Knowler, W. C. (2006) · Clinical Trials · doi:10.1177/1740774506070727 · Cited by 28
Self-citationBrief self-efficacy scales for use in weight-loss trials: Preliminary evidence of validity.
Wilson, K. E., Harden, S. M., Almeida, F. A., You, W., Hill, J. L., Goessl, C. L., & Estabrooks, P. A. (2015) · Psychological Assessment · doi:10.1037/pas0000249 · Cited by 38
Obesity medications: A narrative review of current and emerging agents
Qi, Q., Cox, A., McNeil, S. E., & Sumithran, P. (2024) · Osteoarthritis and Cartilage Open · doi:10.1016/j.ocarto.2024.100472 · Cited by 42
Leporn, N. E., Fouchian, D. D., & McCulloughn, P. A. (2013) · Reviews in Cardiovascular Medicine · doi:10.3909/ricm0682 · Cited by 29
Bray, G. A. (2005) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2004.09.009 · Cited by 29
Epidemiology of Obesity and Pharmacologic Treatment Options
Shettar, V., Patel, S., & Kidambi, S. (2017) · Nutrition in Clinical Practice · doi:10.1177/0884533617713189 · Cited by 26
“5 kg).(70) A 2002 study from Brazil showed a mean weight loss of 10.”
BackgroundLorcaserin for the treatment of obesity
Redman, L. M., & Ravussin, É. (2010) · Drugs of today · doi:10.1358/dot.2010.46.12.1556433 · Cited by 33
Current pharmacotherapy for obesity: extrapolation of clinical trials data to practice
Gadde, K. M. (2014) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2014.890590 · Cited by 29
Antidepressants for polycystic ovary syndrome
Zhuang, J., Wang, X., Xu, L., Wu, T., & Kang, D. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008575.pub2 · Cited by 25
The metabolic syndrome: Diagnosis and treatment
Zieve, F. J. (2004) · Clinical cornerstone · doi:10.1016/s1098-3597(04)80093-0 · Cited by 28
Lifestyle Treatments in Randomized Clinical Trials of Pharmacotherapies for Obesity
Poston, W. S. C., Haddock, C. K., Dill, P. L., Thayer, B., & Foreyt, J. P. (2001) · Obesity Research · doi:10.1038/oby.2001.72 · Cited by 26
Self-citationGao, R., Qi, Z., Lin, J., Wang, G., Chen, G., Yuan, L., & Sun, Q. (2023) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.3c02642 · Cited by 29
Evolving Approaches for Pharmacological Therapy of Obesity
Chao, A. M., Taylor, S. I., Moore, M., Amaro, A., & Wadden, T. A. (2024) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-031124-101146 · Cited by 30
A review of late-stage CNS drug candidates for the treatment of obesity
Heal, D. J., Gosden, J., & Smith, S. L. (2012) · International Journal of Obesity · doi:10.1038/ijo.2012.26 · Cited by 29
Amphetamine derivatives and obesity
Ricca, V., Castellini, G., Mannucci, E., Monami, M., Ravaldi, C., Amedei, S. G., Sauro, C. L., Rotella, C. M., & Faravelli, C. (2008) · Appetite · doi:10.1016/j.appet.2008.11.013 · Cited by 29
A review of the metabolic effects of controlled-release Phentermine/Topiramate
Kiortsis, D. N. (2013) · HORMONES · doi:10.14310/horm.2002.1438 · Cited by 28
Phentermine cardiovascular safety
Rothman, R. B., & Hendricks, E. J. (2009) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2009.07.014 · Cited by 25
Phentermine: A Systematic Review for Plastic and Reconstructive Surgeons
Lim, S., Rogers, L. K., Tessler, O., Mundinger, G. S., Rogers, C. L., & Lau, F. H. (2018) · Annals of Plastic Surgery · doi:10.1097/sap.0000000000001478 · Cited by 20
Igel, L. I., Powell, A. G., Apovian, C. M., & Aronne, L. J. (2011) · Current Atherosclerosis Reports · doi:10.1007/s11883-011-0221-0 · Cited by 22
Approaches to obesity management
Sweeting, A., & Caterson, I. D. (2017) · Internal Medicine Journal · doi:10.1111/imj.13474 · Cited by 25
Khajuria, V., Arora, E., Tandon, V., Sharma, A., Mahajan, A., Gillani, Z., & Choudhary, N. (2015) · Perspectives in Clinical Research · doi:10.4103/2229-3485.148812 · Cited by 21
Overview and the Future of Obesity Treatment
Terre, L., Poston, W. S. C., & Foreyt, J. P. (2005) · Humana Press eBooks · doi:10.1385/1-59259-865-x:161 · Cited by 21
Self-citationParwe, S. D., Mohan, M., Bhagwat, P., & Nisargandha, M. A. (2021) · International Journal of Life Science and Pharma Research · doi:10.22376/ijpbs/lpr.2021.11.1.l30-37 · Cited by 24
Haddock, C. K., Poston, W. S. C., Foreyt, J. P., DiBartolomeo, J. J., & Warner, P. (2008) · Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity · doi:10.1007/bf03327609 · Cited by 19
Self-citationTherapeutic Role of Phytomedicines on Obesity: Importance of Herbal Pancreatic lipase Inhibitors
Singh, S., & Kanwar, S. S. (2013) · Cited by 23
Pulmonary Hypertension Associated with Use of Phentermine
Bang, W.-D., Kim, J., Yu, H.-T., Cho, S.-S., Jang, J., Oh, C., Joung, B., & Chang, H. (2010) · Yonsei Medical Journal · doi:10.3349/ymj.2010.51.6.971 · Cited by 21
Bray, G. A., & Ryan, D. H. (2011) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2011.08.013 · Cited by 21
The Challenge of Obesity Treatment: A Review of Approved Drugs and New Therapeutic Targets
Bonamichi, B. D. S. F., Parente, E. B., dos Santos, R. B., Beltzhoover, R., Lee, J., & Salles, J. E. N. (2018) · Journal of Obesity & Eating Disorders · doi:10.21767/2471-8203.100034 · Cited by 20
Obesity pillars roundtable: Phentermine – Past, present, and future
Bays, H. E., Lazarus, E., Primack, C., & Fitch, A. (2022) · Obesity Pillars · doi:10.1016/j.obpill.2022.100024 · Cited by 22
Kenkre, J. S., Tan, T., & Bloom, S. R. (2013) · Expert Review of Clinical Pharmacology · doi:10.1586/ecp.13.5 · Cited by 17
Prescription Medications for the Treatment of Obesity
Preiato, V. L., Serban, D. E., Pasquali, R., & Pagotto, U. (2014) · Springer eBooks · doi:10.1007/978-3-319-09045-0_23 · Cited by 15
Aagaard, L., Hallgreen, C. E., & Hansen, E. H. (2016) · International Journal of Obesity · doi:10.1038/ijo.2016.135 · Cited by 15
The Effectiveness of Screening for Obesity in Primary Care: Weighing the Evidence
Wilson, A. R., & McAlpine, D. D. (2006) · Medical Care Research and Review · doi:10.1177/1077558706290942 · Cited by 16
Pharmacologic Treatment Options for Obesity: Current and Potential Medications
Fujioka, K., & Lee, M. W. (2007) · Nutrition in Clinical Practice · doi:10.1177/011542650702200150 · Cited by 15
New Antiobesity Agents: Lorcaserin (Belviq) and Phentermine/Topiramate ER (Qsymia)
Shyh, G. I., & Cheng-Lai, A. (2013) · Cardiology in Review · doi:10.1097/crd.0000000000000001 · Cited by 18
Pharmacotherapy for weight loss: the cardiovascular effects of the old and new agents
Walter, C. P., Bleske, B. E., & Dorsch, M. P. (2014) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.12177 · Cited by 18
Muzurović, E. M., Dragnić, S., Medenica, S., Smolović, B., Bulajić, P., & Mikhailidis, D. P. (2020) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2020.107619 · Cited by 17
Tackling obesity: new therapeutic agents for assisted weight loss
McFarlane, S. (2010) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s6552 · Cited by 14
Three- and six-month efficacy and safety of phentermine in a Mexican obese population
Márquez-Cruz, M., Kammar-García, A., Huerta-Cruz, J. C., Carrasco-Portugal, M. D. C., Barranco-Garduño, L. M., Rodríguez-Silverio, J., González, H. I. R., & Reyes-García, J. G. (2021) · Int. Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cp203943 · Cited by 13
“This safety profile is in line with those reported in other studies [11, 22, 26].”
ResultAdulteration of Slimming Products and its Detection Methods
Aldewachi, H. S. (2019) · Global Journal of Pharmacy & Pharmaceutical Sciences · doi:10.19080/gjpps.2019.07.555723 · Cited by 14
Fixed-dose combination of phentermine–topiramate for the treatment of obesity
Halpern, B., Faria, A. M., & Halpern, A. (2013) · Expert Review of Clinical Pharmacology · doi:10.1586/ecp.13.13 · Cited by 13
Kushner, R. F. (2007) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2007.01.004 · Cited by 21
Obesity: an epidemic of the 21st century.
Islam, N. (2005) · PubMed · Cited by 12
Diet and physical activity behavior among users of prescription weight loss medications
Blanck, H. M., Khan, L. K., & Serdula, M. K. (2004) · International Journal of Behavioral Nutrition and Physical Activity · doi:10.1186/1479-5868-1-17 · Cited by 13
de Krom, M., Elburg, A. A. V., ZELISSEN, P. M. J., & Adan, R. A. H. (2006) · Springer eBooks · doi:10.1007/0-387-34577-2_8 · Cited by 14
Pharmacologic Treatment of Obesity in Adults: Standards of Care in Overweight and Obesity
Gudzune, K. A., Apovian, C. M., Aroda, V. R., Aronne, L. J., Balapattabi, K., Bennett, A. K., ChallaSivaKanaka, S., ElSayed, N. A., Fitch, A., Fitzpatrick, S. L., et al. (2026) · Diabetes Obesity and Cardiometabolic CARE · doi:10.2337/doci25-0008 · Cited by 27
Treatment and prevention of obesity: What works, what doesn't work, and what might work
Allison, D. B., & Weber, M. (2003) · Lipids · doi:10.1007/s11745-003-1045-5 · Cited by 17
Effect of antiobesity medications in patients with type 2 diabetes mellitus
Choussein, S., Makri, A., Frangos, C. C., Petridou, E. T., & Daskalopoulou, S. S. (2009) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.01026.x · Cited by 11
Neuromodulation for Eating Disorders
Gorgulho, A. A., Pereira, J. L. B., Krahl, S. E., Lemaire, J., & Salles, A. D. (2013) · Neurosurgery Clinics of North America · doi:10.1016/j.nec.2013.08.005 · Cited by 12
Interactions with Drugs and Dietary Supplements Used For Weight Loss
Melanie, A. (2013) · InTech eBooks · doi:10.5772/51145 · Cited by 11
Pharmacologic treatment of obesity in adults: Standards of care in overweight and obesity
C, K. A. C. M. V. R. L. J. K. A. G. A. A. A. B. B. (2025) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2025-005729 · Cited by 36
Pratt, W. E., & Connolly, M. E. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.08.011 · Cited by 12
Pharmacotherapy for the Obese Patient
Dickerson, L. M., & Carek, P. J. (2009) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2009.01.004 · Cited by 11
Tools for Successful Weight Management in Primary Care
Turer, C. B., & Palmer, B. F. (2015) · The American Journal of the Medical Sciences · doi:10.1097/maj.0000000000000530 · Cited by 12
Adulteration of Slimming Products and its Detection Methods
Aldewachi, H. S., Mustafa, Y. F., Najm, R., & Ammar, F. (2020) · Systematic Reviews in Pharmacy · doi:10.5530/srp.2020.3.33 · Cited by 37
Khairy, M., & Rajkhowa, M. (2017) · The Obstetrician & Gynaecologist · doi:10.1111/tog.12343 · Cited by 10
Pharmacological Treatment of the Overweight Patient
(2007) · Humana Press eBooks · doi:10.1007/978-1-59745-431-5_9 · Cited by 9
Substantial Weight Gain During Adulthood: The Road to Bariatric Surgery
McCullough, P. A., Sandberg, K. R., Miller, W. M., Odom, J., Sloan, K. C., de Jong, A. T., Janosz, K. E. N., Irving, S. D., Krause, K. R., & Franklin, B. A. (2005) · Preventive Cardiology · doi:10.1111/j.1520-037x.2005.3918.x · Cited by 9
Anyanwu, G. O., Qamar, H. M.-U.-D., Iqbal, J., Ejaz, S. A., Onyeneke, E. C., Khan, S. U., Rauf, K., & Rahman, N.-U. (2021) · Tropical Journal of Pharmaceutical Research · doi:10.4314/tjpr.v18i3.15 · Cited by 8
Sibutramine and the sympathetic nervous system in obese humans
Haynes, W. G., & Egri, Z. (2005) · Clinical Autonomic Research · doi:10.1007/s10286-005-0287-2 · Cited by 8
Psychopharmacologic Treatment of Obesity and Eating Disorders in Children and Adolescents
Powers, P. S., & Cloak, N. L. (2012) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2012.07.003 · Cited by 10
Rodriguez, N. S., & Hartmann, P. (2025) · Pharmacological Reviews · doi:10.1016/j.pharmr.2025.100058 · Cited by 13
Hoisington, A. J., Stearns‐Yoder, K. A., Stamper, C. E., Simonetti, J. A., Oslin, D. W., & Brenner, L. A. (2024) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.20220221 · Cited by 7
Farmakoterapia otyłości — obecny stan wiedzy
Matyjaszek‐Matuszek, B., Szafraniec, A., & Porada, D. (2018) · Endokrynologia Polska · doi:10.5603/ep.2018.0048 · Cited by 13
Is new hope on the horizon for obesity?
Bray, G. A. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61792-4 · Cited by 7
Pharmacological interventions for reducing weight gain in schizophrenia
Hahn, M., Remington, G. J., Duncan, M. J., Cohn, T. A., & Faulkner, G. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011127 · Cited by 6
Combination Phentermine/Topiramate for Obesity Treatment in Primary Care: A Review
Xiong, G. L., & Gadde, K. M. (2014) · Postgraduate Medicine · doi:10.3810/pgm.2014.03.2746 · Cited by 7
An Integrative Approach to Obesity
Nicolai, J. P., Lupiani, J. H., & Wolf, A. J. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-1793-8.00038-8 · Cited by 10
Bano, F., Ahmed, A., Ahmed, M., & Parveen, T. (2015) · Pakistan Journal of Pharmaceutical Sciences · doi:10.36721/pjps/28/1/01.01.2015/3433/221-225 · Cited by 10
Integrated Approach to Treatment and Prevention
Scheen, A. J. (2004) · CRC Press eBooks · doi:10.1201/9780203508756-36 · Cited by 9
Optimal diabetes management during medical weight loss for cardiovascular risk reduction
Janosz, K. E. N., Miller, W. M., Odom, J., Lillystone, M. A., Yanez, J., & McCullough, P. A. (2005) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.3.4.761 · Cited by 6
Jeong, S., Yun, S. B., Park, S. Y., & Mun, S. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1257861 · Cited by 6
Tratamiento farmacológico o quirúrgico del paciente con sobrepeso u obesidad
Carrasco, F., Manrique, M., de la Maza, M. P., Moreno, M., Albala, C., García, J., Díaz, J., & Liberman, C. (2009) · Revista médica de Chile · doi:10.4067/s0034-98872009000700017 · Cited by 12
Pharmacotherapy for Weight Management
Brett, E. M. (2018) · Springer eBooks · doi:10.1007/978-3-319-95655-8_21 · Cited by 6
Pharmacological Management of Obesity: A Century of Expert Opinions in Cecil Textbook of Medicine
Manu, P., Lăcătușu, C.-M., Rogozea, L. M., & Cernea, S. (2022) · American Journal of Therapeutics · doi:10.1097/mjt.0000000000001524 · Cited by 12
Contemporary approaches to adult Obesity treatment
Meires, J., & Christie, C. (2011) · The Nurse Practitioner · doi:10.1097/01.npr.0000403291.15266.d6 · Cited by 6
Antiepileptic Drugs in Obesity, Psychotropic-Associated Weight Gain, and Eating Disorders
McElroy, S. L., Guerdjikova, A. I., Keck, P. E., Pope, H. G., & Hudson, J. I. (2008) · Medical psychiatry · doi:10.3109/9780849382666.016 · Cited by 6
Pharmacologic Agents Chapter for Abdominal Obesity
Nuffer, W. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816093-0.00005-7 · Cited by 8
Diets, drugs, exercise, and behavioral modification: Where these work and where they do not
Kushner, R. F. (2005) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2005.01.008 · Cited by 5
Treatment options for obesity and potential therapies on the horizon.
Motycka, C. A., Onge, E. S., & Miller, S. A. (2011) · PubMed Central · Cited by 6
An Integrative Approach to Obesity
Nicolai, J. P., Lupiani, J. H., & Wolf, A. J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35868-2.00037-2 · Cited by 6
Pharmacotherapy and surgery in the treatment of obesity: evaluating risks and benefits
Sum, C. F. (2002) · Asia Pacific Journal of Clinical Nutrition · doi:10.1046/j.1440-6047.11.s8.15.x · Cited by 4
Prevention and Treatment of Obesity and Diabetes and their Related Complications
Song, M. K. (2014) · Journal of Molecular and Genetic Medicine · doi:10.4172/1747-0862.s1-009 · Cited by 4
A case of profound weight loss secondary to use of phentermine.
Uwaifo, G. I., Melcescu, E., McDonald, A., & Koch, C. A. (2009) · PubMed · Cited by 4
Antiobesity drug therapy: a call for more rigorous end-point evaluation
Padwal, R. S. (2007) · Therapy · doi:10.2217/14750708.4.3.221 · Cited by 4
Cohen, R. A. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000137187.16206.79 · Cited by 6
Nutrition and reproduction in women The ESHRE Capri Workshop Group 1
Crosignani, P. G. (2006) · Cited by 4
Nugraha, G. I., Amalia, F. I., Imadudda’wah, F., Ariyanto, E. F., Ghozali, M., & Fatimah, S. N. (2024) · Medicine · doi:10.1097/md.0000000000039908 · Cited by 6
Metadata
- Authors
- Haddock, C., Poston, W., Dill, P., Foreyt, J., & Ericsson, M.
- Affiliations
- Saint Luke's Hospital (US)
- University of Missouri–Kansas City (US)
- Venue
- International Journal of Obesity
- Published
- 2002-02
- Volume
- 26
- Issue
- 2
- Pages
- 262-273
- ISSN
- 0307-0565 (ISSN-L)
- 1476-5497
- OpenAlex
- W2069004141
- Cited by
- 303
- References
- 23
- Citations by year
- 2026: 7 · 2025: 5 · 2024: 5 · 2023: 5 · 2022: 6 · 2021: 11 · 2020: 6 · 2019: 6 · 2018: 12 · 2017: 13 · 2016: 9 · 2015: 17 · 2014: 8 · 2013: 21 · 2012: 15
- FWCI
- 12.71
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- International Journal of Obesity (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity, Physical Activity, Diet
- Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
- Keywords
- obesity pharmacotherapy, anti-obesity drugs, weight loss, amphetamine, fenfluramine, sibutramine, benzphetamine, combination therapy, placebo effect, drug efficacy comparison, methodological factors
- MeSH terms
- Amphetamines, Benzphetamine, Cyclobutanes, Fenfluramine, Humans, Obesity, Randomized Controlled Trials as Topic, Anti-Obesity Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.